Thu, January 18, 2024
Wed, January 17, 2024
Tue, January 16, 2024
Mon, January 15, 2024
Fri, January 12, 2024
Thu, January 11, 2024
Wed, January 10, 2024

David Amsellem Maintained (AXSM) at Buy with Increased Target to $113 on, Jan 16th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-113-on-jan-16th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Amsellem of Piper Sandler, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $90 to $113 on, Jan 16th, 2024.

David has made no other calls on AXSM in the last 4 months.



There are 4 other peers that have a rating on AXSM. Out of the 4 peers that are also analyzing AXSM, 0 agree with David's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with David


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $180 on, Tuesday, December 26th, 2023
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $108 on, Wednesday, December 20th, 2023
  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $125 on, Wednesday, December 13th, 2023
  • Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $100 on, Monday, September 25th, 2023

Publication Contributing Sources